Peginterferon Beta-1a Reduces the Evolution of MRI Lesions to Black Holes in Patients With RRMS: A Post Hoc Analysis From the ADVANCE Study

Journal of Neurology - Germany
doi 10.1007/s00415-017-8544-6
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Hematologic Responses in Patients With Aplastic Anemia Treated With Deferasirox: A Post Hoc Analysis From the EPIC Study

Haematologica
Hematology
2013English

BG-12 Reduces Evolution of New Enhancing Lesions to T1-Hypointense Lesions in Patients With Multiple Sclerosis

Journal of Neurology
Neurology
2010English

Cost-Effectiveness Analysis of Peginterferon Beta-1a in the Treatment of Relapsing-Remitting Multiple Sclerosis in Italy: Results of an Updated Analysis

Farmeconomia. Health economics and therapeutic pathways
2018English

Pnd34 - Payer and Societal Benefit of Peginterferon Beta-1a Versus Glatiramer Acetate in Patients With Relapsing-Remitting Multiple Sclerosis in Spain

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Borderline Pulmonary Arterial Pressure in Systemic Sclerosis Patients: A Post-Hoc Analysis of the DETECT Study

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2014English

Pnd33 - Payer and Societal Benefit of Peginterferon Beta-1a Versus Glatiramer Acetate in Patients With Relapsing-Remitting Multiple Sclerosis in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

P1.01-107 the Impact of Anlotinib on Quality of Life in Patients With Advance NSCLC: Post-Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Management Strategies for Flu-Like Symptoms and Injection-Site Reactions Associated With Peginterferon Beta-1a

International Journal of MS Care
NeurologySpecialized NursingAdvanced
2016English

Relapse Rate and MRI Activity in Young Adult Patients With Multiple Sclerosis: A Post Hoc Analysis of Phase 3 Fingolimod Trials

Multiple Sclerosis Journal - Experimental, Translational and Clinical
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy